Avalo Therapeutics’ (AVTX) Neutral Rating Reiterated at HC Wainwright
HC Wainwright restated their neutral rating on shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) in a research report report published on Thursday morning,Benzinga reports. A number of other brokerages also recently issued reports on AVTX. BTIG Research initiated coverage on Avalo Therapeutics in a report on Thursday, December 19th. They set a “buy” rating […]
HC Wainwright restated their neutral rating on shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) in a research report report published on Thursday morning,Benzinga reports. A number of other brokerages also recently issued reports on AVTX. BTIG Research initiated coverage on Avalo Therapeutics in a report on Thursday, December 19th. They set a “buy” rating […]
